Gene · 476
Papers2,080
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,080
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. | Nat Biotechnol | 2023 | 36217030 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Reciprocal interaction between vascular niche and sweat gland promotes sweat gland regeneration. | Bioact Mater | 2023 | 36185745 | PubTator, text mining | PubMed |
| Newfound Coding Potential of Transcripts Unveils Missing Members of Human Protein Communities. | Genomics Proteomics Bioinformatics | 2023 | 36183975 | PubTator, text mining | PubMed |
| LncRNA ATP1A1-AS1 inhibits cell proliferation and promotes cell apoptosis in thyroid carcinoma by regulating the miR-620/IRF2BP2 axis. | Am J Med Sci | 2023 | 36002076 | PubTator, text mining | PubMed |
| Adverse effect of FTY720P on colonic Na+ /K+ ATPase is mediated via ERK, p38MAPK, PKC, and PI3K. | J Appl Toxicol | 2023 | 35946054 | PubTator, text mining | PubMed |
| Timed use of digoxin prevents heart ischemia-reperfusion injury through a REV-ERBα-UPS signaling pathway. | Nat Cardiovasc Res | 2022 | 38229609 | PubTator, text mining | PubMed |
| Proteomics research of SARS-CoV-2 and COVID-19 disease. | Med Rev (2021) | 2022 | 37724330 | PubTator, text mining | PubMed |
| Signatures of muscle disuse in spaceflight and bed rest revealed by single muscle fiber proteomics. | PNAS Nexus | 2022 | 36741463 | PubTator, text mining | PubMed |
| Hypoxia signaling pathway: A central mediator in endocrine tumors. | Front Endocrinol (Lausanne) | 2022 | 36699028 | PubTator, text mining | PubMed |
| Na+/K+‑ATPase subunit α3 expression is associated with the efficacy of digitoxin treatment in pancreatic cancer cells. | Med Int (Lond) | 2022 | 36698913 | PubTator, text mining | PubMed |
| Therapeutic Potency of Induced Pluripotent Stem-Cell-Derived Corneal Endothelial-like Cells for Corneal Endothelial Dysfunction. | Int J Mol Sci | 2022 | 36614165 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of Na+, K+-ATPase Regulation through Phosphorylation of the Alpha-Subunit N-Terminus. | Int J Mol Sci | 2022 | 36613508 | PubTator, text mining | PubMed |
| Macrophage Resistance to Ionizing Radiation Exposure Is Accompanied by Decreased Cathepsin D and Increased Transferrin Receptor 1 Expression. | Cancers (Basel) | 2022 | 36612268 | PubTator, text mining | PubMed |
| SARS-CoV-2 (COVID-19) as a possible risk factor for neurodevelopmental disorders. | Front Neurosci | 2022 | 36590303 | PubTator, text mining | PubMed |
| Ectopic localization of CYP11B1 and CYP11B2-expressing cells in the normal human adrenal gland. | PLoS One | 2022 | 36584094 | PubTator, text mining | PubMed |
| Clinical identification of expressed proteins in adrenal medullary hyperplasia detected with hypertension. | Front Endocrinol (Lausanne) | 2022 | 36583008 | PubTator, text mining | PubMed |
| Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and Non-Viral Etiology. | Medicina (Kaunas) | 2022 | 36557005 | PubTator, text mining | PubMed |
| EIF4G1 Is a Potential Prognostic Biomarker of Breast Cancer. | Biomolecules | 2022 | 36551184 | PubTator, text mining | PubMed |
| Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II. | Ann Clin Case Rep | 2022 | 36540866 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/476/papers?page=16